Colon-specific delivery tablets of sodium 4-aminosalicylic acid

Yaoxue Xuebao

Volumn 41, Issue 10, 2006, Pages 927-932

  Li, Yan ^a   Li, Hong Jian ^a   Yang, Guo Ren ^b   Gu, Wei Ping ^a   Ma, Yu Kui ^c   Zhang, Man Hong ^c   Sun, Jie ^c   Sun, Shu Juan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^c Shandong Institute of Pharmaceutical Industry   (China)

Author keywords

scintigraphy; Acrylic resin; Colon specific; Sodium 4 aminosalicylic acid

Indexed keywords

ACRYLIC ACID RESIN; AMINOSALICYLIC ACID; EUDRAGIT RS; TUBERCULOSTATIC AGENT;

ANIMAL; ARTICLE; CHEMISTRY; COLON; DELAYED RELEASE FORMULATION; DOG; DRUG DELIVERY SYSTEM; ENTERIC COATED TABLET; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; PH;

ACRYLIC RESINS; ADMINISTRATION, ORAL; ANIMALS; ANTITUBERCULAR AGENTS; COLON; DELAYED-ACTION PREPARATIONS; DOGS; DRUG DELIVERY SYSTEMS; HYDROGEN-ION CONCENTRATION; MALE; P-AMINOSALICYLIC ACID; TABLETS, ENTERIC-COATED;

EID: 33845365609     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Marteau P, Halphen M. Comparative randomized open study of the efficacy and tolerance of enemas with 2g of 4-ASA and 1g of 5-ASA in distal forms of hemorrhagic recto colitis [J]. Gastroenterol Clin Biol, 1995, 19:31-35.
2. Marshall JK, Irvine EJ. Rectal aminosalicylate therapy for distal ulcerative colitis: a meta analysis [J]. Aliment Pharmacol Ther, 1995, 9:293-300.
3. Campieri M, Lanfranchi GA, Bertoni F, et al. A double-blind clinical trial to compare the effects of 4-aminosalicylic acid and 5-aminosalicylic acid in topical treatment of ulcerative colitis [J]. Digestion, 1984, 29: 204-208.
4. Sharma MP, Duphare HV. 4-Aminosalicylic acid enemas for ulcerative colitis [J]. Lancet, 1989, 1:450.
5. Forbes RT, York P, Davidson JR. Dissolution kinetics and solubilities of p-aminosalicylic acid and its salts [J]. Int J Pharm, 1995, 126:199-208.
6. Davis SS, Hardy JG, Newman SP, et al. Gamma scintigraphy in the evaluation of pharmaceutical dosage forms [J]. Eur J Nucl Med, 1992, 19:971-986.
7. Ishibashi T, Pitcairn GR, Yoshino H, et al. Scintigraphic evaluation of a new capsule-type colon-specific drug delivery system in healthy volunteers [J]. J Pharm Sci, 1998, 87:531-535.
8. Gupta VK, Beckert TE, Price JC. A novel pH and time-based multi-unit potential colonic drug delivery system. I. Development [J]. Int J Pharm, 2001, 213:83-91.
9. Pye G, Evans DF, Ledinghan S, et al. Gastrointestinal intraluminal pH in normal subjects and those with colorectal adenoma or carcinoma [J]. Gut, 1990, 31:1355-1357.
10. Wilding IR, Hardy JG, Sparrow RA, et al. In vivo evaluation of enteric coated naproxan tablets using gamma scintigraphy [J]. Pharm Res, 1992, 9:1436-1441.
11. Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery systems [J]. J Pharm Pharm Sci, 2003, 6:33-66.